20 Apr 2007

UCB Announces Positive Top-Line Phase III Results for Keppra® as Adjunctive Therapy for Partial Onset Seizures in Paediatric Patients from One Month to Less than Four Years of Age

Read More
23 Mar 2007

UCB Provides Update on CIMZIA(TM) for Crohn's Disease and Rheumatoid Arthritis in the US

Read More
20 Mar 2007

Keppra® Approved for US Epilepsy Patients with One of the Most Debilitating Seizure Types

Read More
12 Mar 2007

New European Approval for Xyrem® Provides Significant Advance in the Treatment of Narcolepsy

Read More
8 Mar 2007

UCB has sold successfully its stake in Cytec Industries

Read More
28 Feb 2007

UCB Full-Year 2006 Financial Results

Read More
23 Feb 2007

Significant Phase III Results with CIMZIA(TM) in Rheumatoid Arthritis

Read More
9 Feb 2007

Financière de Tubize strengthens its shareholding in UCB

Read More
6 Feb 2007

UCB gains global rights pertaining to VEGFR-2 for CDP-791

Read More
25 Jan 2007

European Medicines Agency Adopts Positive Opinion Recommending Approval of Xyrem® for the Treatment of Narcolepsy with Cataplexy in Adult Patients

Read More
Subscribe to